Literature DB >> 35522620

Intrinsic features of Zika Virus non-structural proteins NS2A and NS4A in the regulation of viral replication.

Yufeng Yu1, Chengfeng Gao2, Chunxia Wen2, Peng Zou3, Xian Qi4, Carol J Cardona5, Zheng Xing2,5.   

Abstract

Zika virus (ZIKV) is a mosquito-borne flavivirus and can cause neurodevelopmental disorders in fetus. As a neurotropic virus, ZIKV persistently infects neural tissues during pregnancy but the viral pathogenesis remains largely unknown. ZIKV has a positive-sense and single-stranded RNA genome, which encodes 7 non-structural (NS) proteins, participating in viral replication and dysregulation of host immunity. Like those in many other viruses, NS proteins are considered to be products evolutionarily beneficiary to viruses and some are virulence factors. However, we found that some NS proteins encoded by ZIKV genome appeared to function against the viral replication. In this report we showed that exogenously expressed ZIKV NS2A and NS4A inhibited ZIKV infection by inhibiting viral RNA replication in microglial cells and astrocytes. To understand how viral NS proteins suppressed viral replication, we analyzed the transcriptome of the microglial cells and astrocytes and found that expression of NS4A induced the upregulation of ISGs, including MX1/2, OAS1/2/3, IFITM1, IFIT1, IFI6, IFI27, ISG15 or BST2 through activating the ISGF3 signaling pathway. Upregulation of these ISGs seemed to be related to the inhibition of ZIKV replication, since the anti-ZIKV function of NS4A was partially attenuated when the cells were treated with Abrocitinib, an inhibitor of the ISGF3 signaling pathway, or were knocked down with STAT2. Aborting the protein expression of NS4A, but not its nucleic acid, eliminated the antiviral activity of NS4A effectively. Dynamic expression of viral NS proteins was examined in ZIKV-infected microglial cells and astrocytes, which showed comparatively NS4A occurred later than other NS proteins during the infection. We hypothesize that NS4A may possess intrinsic features to serve as a unique type of pathogen associated molecular pattern (PAMP), detectable by the cells to induce an innate immune response, or function with other mechanisms, to restrict the viral replication to a certain level as a negative feedback, which may help ZIKV maintain its persistent infection in fetal neural tissues.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35522620      PMCID: PMC9075646          DOI: 10.1371/journal.pntd.0010366

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  62 in total

1.  Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-α1 degradation.

Authors:  Chunyang Wang; Menghuai Sun; Xinhui Yuan; Lianfu Ji; Yu Jin; Carol J Cardona; Zheng Xing
Journal:  J Biol Chem       Date:  2017-04-28       Impact factor: 5.157

2.  Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis.

Authors:  Priya S Shah; Nichole Link; Gwendolyn M Jang; Phillip P Sharp; Tongtong Zhu; Danielle L Swaney; Jeffrey R Johnson; John Von Dollen; Holly R Ramage; Laura Satkamp; Billy Newton; Ruth Hüttenhain; Marine J Petit; Tierney Baum; Amanda Everitt; Orly Laufman; Michel Tassetto; Michael Shales; Erica Stevenson; Gabriel N Iglesias; Leila Shokat; Shashank Tripathi; Vinod Balasubramaniam; Laurence G Webb; Sebastian Aguirre; A Jeremy Willsey; Adolfo Garcia-Sastre; Katherine S Pollard; Sara Cherry; Andrea V Gamarnik; Ivan Marazzi; Jack Taunton; Ana Fernandez-Sesma; Hugo J Bellen; Raul Andino; Nevan J Krogan
Journal:  Cell       Date:  2018-12-13       Impact factor: 41.582

Review 3.  The emergence of Zika virus and its new clinical syndromes.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Nature       Date:  2018-08-29       Impact factor: 49.962

4.  Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins.

Authors:  D Moradpour; P Kary; C M Rice; H E Blum
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

5.  Zika Virus Infects Human Fetal Brain Microglia and Induces Inflammation.

Authors:  Fok-Moon Lum; Donovan K S Low; Yiping Fan; Jeslin J L Tan; Bernett Lee; Jerry K Y Chan; Laurent Rénia; Florent Ginhoux; Lisa F P Ng
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

6.  The ER Membrane Protein Complex Promotes Biogenesis of Dengue and Zika Virus Non-structural Multi-pass Transmembrane Proteins to Support Infection.

Authors:  David L Lin; Takamasa Inoue; Yu-Jie Chen; Aaron Chang; Billy Tsai; Andrew W Tai
Journal:  Cell Rep       Date:  2019-05-07       Impact factor: 9.423

Review 7.  The role of microglia in viral encephalitis: a review.

Authors:  Zhuangzhuang Chen; Di Zhong; Guozhong Li
Journal:  J Neuroinflammation       Date:  2019-04-09       Impact factor: 8.322

8.  Zika Virus Non-Structural Protein NS5 Inhibits the RIG-I Pathway and Interferon Lambda 1 Promoter Activation by Targeting IKK Epsilon.

Authors:  Rickard Lundberg; Krister Melén; Veera Westenius; Miao Jiang; Pamela Österlund; Hira Khan; Olli Vapalahti; Ilkka Julkunen; Laura Kakkola
Journal:  Viruses       Date:  2019-11-04       Impact factor: 5.048

9.  Microglial identity and inflammatory responses are controlled by the combined effects of neurons and astrocytes.

Authors:  Paul S Baxter; Owen Dando; Katie Emelianova; Xin He; Sean McKay; Giles E Hardingham; Jing Qiu
Journal:  Cell Rep       Date:  2021-03-23       Impact factor: 9.423

10.  Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.

Authors:  Yasuhiro Itsui; Naoya Sakamoto; Sei Kakinuma; Mina Nakagawa; Yuko Sekine-Osajima; Megumi Tasaka-Fujita; Yuki Nishimura-Sakurai; Gouki Suda; Yuko Karakama; Kako Mishima; Machi Yamamoto; Takako Watanabe; Mayumi Ueyama; Yusuke Funaoka; Seishin Azuma; Mamoru Watanabe
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.